Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polypyrimidine tract-binding protein interacts with HnRNP L

B Hahm1, O H Cho, J E Kim

  • 1Department of Life Science, Pohang University of Science and Technology, Kyungbuk, South Korea.

FEBS Letters
|May 1, 1998
PubMed
Summary

Polypyrimidine tract-binding protein (PTB) interacts with heterogeneous nuclear ribonucleoprotein L (hnRNP L). This interaction, confirmed in vitro, occurs in the nucleoplasm and requires specific protein domains for binding.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies.

ESMO open·2026
Same author

Phase II trial, multicenter, first-line paclitaxel-avelumab treatment of inoperable angiosarcoma (KCSG UN 18-15).

ESMO open·2026
Same author

Lactobacillus paragasseri SBT2055 suppressed insulin resistance and fatty liver by inhibiting oxidative stress and inflammation in high-fat diet-induced obese mice.

Beneficial microbes·2025
Same author

Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS<sup>G12C</sup> inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Differentiation between Chondrosarcoma and Synovial Chondromatosis of the Temporomandibular Joint Using CT and MR Imaging.

AJNR. American journal of neuroradiology·2023
Same author

Safety and efficacy of trastuzumab biosimilar plus irinotecan or gemcitabine in patients with previously treated HER2 (ERBB2)-positive non-breast/non-gastric solid tumors: a phase II basket trial with circulating tumor DNA analysis.

ESMO open·2023

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Polypyrimidine tract-binding protein (PTB) plays a crucial role in pre-mRNA splicing and internal ribosomal entry site (IRES)-dependent translation.
  • Identifying interacting partners of PTB is essential for understanding its regulatory functions in gene expression.

Purpose of the Study:

  • To identify cellular proteins that interact with Polypyrimidine tract-binding protein (PTB).
  • To characterize the interaction between PTB and its binding partners at the molecular and cellular level.

Main Methods:

  • Yeast two-hybrid screening was employed to identify PTB-interacting proteins.
  • In vitro binding assays were used to confirm the interaction.
  • Green fluorescent protein (GFP)-fused protein detection was utilized to determine cellular localization in HeLa cells.

Related Experiment Videos

Main Results:

  • Heterogeneous nuclear ribonucleoprotein L (hnRNP L) was identified as a PTB-binding protein.
  • The interaction between PTB and hnRNP L was validated through in vitro binding assays.
  • Both PTB and hnRNP L were found to localize in the nucleoplasm, excluding nucleoli.
  • The N-terminal half of PTB (amino acids 1-329) and a significant portion of hnRNP L (amino acids 141-558) are necessary for their interaction.

Conclusions:

  • Heterogeneous nuclear ribonucleoprotein L (hnRNP L) is a novel binding partner of Polypyrimidine tract-binding protein (PTB).
  • The interaction between PTB and hnRNP L is functionally significant and occurs within the nucleoplasm.
  • Specific domains within PTB and hnRNP L mediate their interaction, providing insights into the molecular basis of this complex.